We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 366 results
  1. Superenhancers as master gene regulators and novel therapeutic targets in brain tumors

    Transcriptional deregulation, a cancer cell hallmark, is driven by epigenetic abnormalities in the majority of brain tumors, including adult...

    Hai-Hui Zhuang, Qiang Qu, ... Jian Qu in Experimental & Molecular Medicine
    Article Open access 01 February 2023
  2. Therapeutic Implication of Oxidative Stress Regulators in Drug-Resistant Cancers

    Although initial clinical responses to current standard chemotherapies are often dramatic, a significant number of cancer patients develop drug...
    Qingbin Cui, **g-Quan Wang, ... Zhe-Sheng Chen in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  3. Therapeutic Implication of Oxidative Stress Regulators in Drug-Resistant Cancers

    Although initial clinical responses to current standard chemotherapies are often dramatic, a significant number of cancer patients develop drug...
    Qingbin Cui, **g-Quan Wang, ... Zhe-Sheng Chen in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  4. Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth

    Cerebral organoids co-cultured with patient derived glioma stem cells (GLICOs) are an experimentally tractable research tool useful for investigating...

    J. G. Nicholson, S. Cirigliano, ... H. A. Fine in Acta Neuropathologica Communications
    Article Open access 25 March 2024
  5. RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis

    Objective

    Evidence suggests that calcium release from the endoplasmic reticulum (ER) can be induced to cause calcium overload, which in turn can...

    Hui Yao, Siyu Zhang, ... Bo You in Cellular Oncology
    Article Open access 23 March 2023
  6. A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma

    Glioma progression seriously correlates to the epigenetic context. This study aims to identify glioma subtypes by clustering analysis of patients...

    Sizhong Guan, Ye He, ... Li** Zhou in Cellular and Molecular Neurobiology
    Article 25 August 2021
  7. MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma

    Glioblastoma (GBM) is an aggressive nervous system tumor with a poor prognosis. Although, surgery, radiation therapy, and chemotherapy are the...

    Mahsa Palizkaran Yazdi, Amirhosein Barjasteh, Meysam Moghbeli in Molecular Brain
    Article Open access 02 July 2024
  8. TGF-β-activated circRYK drives glioblastoma progression by increasing VLDLR mRNA expression and stability in a ceRNA- and RBP-dependent manner

    Background

    The TGF-β signalling pathway is intricately associated with the progression of glioblastoma (GBM). The objective of this study was to...

    Yuhang Wang, Binbin Wang, ... **upeng Xu in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 March 2024
  9. Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer

    Background

    While emerging evidence indicates that N 6 -methyladenosine (m 6 A) regulators play crucial roles in cancer progression, their clinical...

    Tadanobu Shimura, Raju Kandimalla, ... Ajay Goel in British Journal of Cancer
    Article 21 October 2021
  10. E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities

    Background

    Human malignancies are composed of heterogeneous subpopulations of cancer cells with phenotypic and functional diversity. Among them, a...

    Qiang Zou, Meng Liu, ... Bin Wang in Cellular Oncology
    Article 06 February 2023
  11. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells

    Background

    Intratumoral heterogeneity is the primary challenge in the treatment of glioblastoma (GBM). The presence of glioma stem cells (GSCs) and...

    Zijie Gao, Jianye Xu, ... Gang Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 November 2022
  12. The Critical Role of RNA m6A Methylation in Gliomas: Targeting the Hallmarks of Cancer

    Gliomas are the most common central cancer with high aggressive-capacity and poor prognosis, remaining to be the threat of most patients. With the...

    Zhouhan Xu, Jun Jiang, Shun Wang in Cellular and Molecular Neurobiology
    Article 15 September 2022
  13. Off the Clock: the Non-canonical Roles of Cyclin-Dependent Kinases in Neural and Glioma Stem Cell Self-Renewal

    Glioma stem cells (GSCs) are thought to drive growth and therapy resistance in glioblastoma (GBM) by “hijacking” at least a subset of signaling...

    Ling-Kai Shih, Subhas Mukherjee, Daniel J. Brat in Molecular Neurobiology
    Article 31 August 2022
  14. Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape

    Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized the treatment of many types of cancer, particularly advanced-stage...

    Wei Li, Yi Hao, ... Da Pang in Molecular Cancer
    Article Open access 07 September 2022
  15. Circadian rhythms in the blood–brain barrier: impact on neurological disorders and stress responses

    Circadian disruption has become more prevalent in society due to the increase in shift work, sleep disruption, blue light exposure, and travel via...

    Nicolette Schurhoff, Michal Toborek in Molecular Brain
    Article Open access 12 January 2023
  16. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications

    With the application of high throughput sequencing technologies at single-cell resolution, studies of the tumor microenvironment in glioblastoma, one...

    Rui Sun, Albert H. Kim in Cancer and Metastasis Reviews
    Article Open access 03 August 2022
  17. Glioma stem cells invasive phenotype at optimal stiffness is driven by MGAT5 dependent mechanosensing

    Background

    Glioblastomas stem-like cells (GSCs) by invading the brain parenchyma, remains after resection and radiotherapy and the tumoral...

    Emilie Marhuenda, Christine Fabre, ... Norbert Bakalara in Journal of Experimental & Clinical Cancer Research
    Article Open access 24 April 2021
  18. Sha** the brain vasculature in development and disease in the single-cell era

    The CNS critically relies on the formation and proper function of its vasculature during development, adult homeostasis and disease. Angiogenesis —...

    Thomas Wälchli, Jeroen Bisschop, ... Ivan Radovanovic in Nature Reviews Neuroscience
    Article 20 March 2023
  19. Emerging role of m6A methylation modification in ovarian cancer

    m6A (N6-methyladenosine) methylation, a well-known modification in tumour epigenetics, dynamically and reversibly fine tunes the entire process of...

    Lin-Lin Chang, **a-Qing Xu, ... Wen-Zhou Zhang in Cancer Cell International
    Article Open access 11 December 2021
  20. m6A modification: recent advances, anticancer targeted drug discovery and beyond

    Abnormal N6-methyladenosine (m6A) modification is closely associated with the occurrence, development, progression and prognosis of cancer, and...

    Li-Juan Deng, Wei-Qing Deng, ... Zhe-Sheng Chen in Molecular Cancer
    Article Open access 14 February 2022
Did you find what you were looking for? Share feedback.